Skip to main navigation Skip to search Skip to main content

Desarrollo de neoplasias secundarias después del trasplante de progenitores hematopoyéticos realizado en edad pediátrica

Student thesis: Doctoral thesis

Abstract

INTRODUCTION_x000D_ Hematopoietic stem cell transplantation (HSCT) is a medical procedure that allows the cure of many paediatric diseases. It has been described an increased risk of new malignancies in this population and it represents an important cause of late mortality._x000D_ The purpose of this study is to analyse the incidence of secondary malignancies and the associated risk factors. _x000D_ _x000D_ PATIENTS AND METHODS_x000D_ We analyzed the late evolution of 371 patients submitted at pediatric age to hematopoietic transplantation (HSCT) (allogeneic or autologous) in Santa Creu i Sant Pau Hospital between 1984 and 2013._x000D_ It has been calculated the cumulative incidence of secondary malignancies at 30 years of follow-up. It has been done univariate and multivariate analysis of risk factors through Chi-squared test and binary logistic regression method (Odds Ratio). It has been studied the risk excess for new malignancies through comparison of observed cases in our cohort with the expected cases in the general population by using Chi-squared test._x000D_ RESULTS_x000D_ We observed 19 cases of secondary malignancies with a cumulative incidence of 6% at 15 years, 12% at 20 years and 36% at 30 years of follow-up._x000D_ The risk was higher of expected in general population for each tumor type and in the different range of age. _x000D_ Chronic graft versus host disease, total body irradiation of conditioning and previous radiotherapy were the factors related with an increased risk. _x000D_ Mortality was 42% between patients with a new malignancy and it was the cause of death for all the cases._x000D_ _x000D_ _x000D_ _x000D_ CONCLUSION_x000D_ We observed an incidence of secondary malignancies after HSCT of 5.1% that is significantly higher compared to the expected in the general population (p=0,000). The factors that have been related to an increased risk were chronic GvHD (graft versus host disease), TBI and radiotherapy administered previously.
Date of Award4 Nov 2016
Original languageUndefined/Unknown
Awarding Institution
  • Hospital de la Santa Creu i Sant Pau
SupervisorIsabel Badell Serra (Director)

Cite this

'